The Final Evaluation Report is a document to be shared with stakeholders interested in the implementation and impact of Financial Support for Third Parties (FSTP) as part of BioMan4R2 Support Programme which supported small and medium-sized enterprises (SMEs) in the adoption of new technology or making use of services to become more resilient, sustainable and/or digital. Increasing the resilience of companies through
direct financial support should also help to strengthen the entire BMT ecosystem and build more reliable, less disruptive supply and value chains. The document provides all details for the whole final evaluation process and the referring requirements for projects received FSTP through the BioMan4R2 Support Programme, such as project timeline, contribution of project partners or service providers, status of key performance indicators (KPIs) and amendments made to achieve envisaged KPIs. In addition, the impact according to several key aspects defined in the application process is evaluated to get insights on how the FSTP helped the companies to improve their current status.

The BioMan4R2 Support Programme aimed to improve manufacturing processes, transfer disruptive medical technologies, strengthen the competitiveness and sustainability of the European healthcare ecosystem by fostering long-term collaboration among SMEs, investment funds, research, clinical and knowledge-intensive organizations, science and technology parks and other companies in these sectors